Contact
searchSearch
HMP Global
Login

Blogs Landing Page

Blogs

Quality Outlook
Every Second Counts: the Impact of FDA’s Accelerated Approval Program
03/05/2025
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research...
03/05/2025
Journal of Clinical Pathways
David Blaisdell
Quality Outlook
Measuring Adherence to Oral Anticancer Medications: A Persistent Problem
06/06/2024
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the...
06/06/2024
Journal of Clinical Pathways
Veronica Ellis
Quality Outlook
Transform HIV Prevention in Your Practice With a New Quality Initiative
05/01/2024
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an...
05/01/2024
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
Anne DiSalvo.
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination
10/03/2023
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part...
10/03/2023
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Jacqlyn Riposo
Quality Outlook
Focus on Outcomes: Quality Measurement Recommendations for CMS’ Medicaid Cell and Gene Therapy Access Model
06/08/2023
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers...
06/08/2023
Journal of Clinical Pathways
Sarena Ho, MSPH
Quality Outlook
Quality Measures for Medicare’s Enhancing Oncology Model (EOM): New and Improved or More of the Same?
01/26/2023
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center...
01/26/2023
Journal of Clinical Pathways
Nina Regenold, MSc
Quality Outlook
The Oncology-Oral Health Value Bridge: Put Your Money Where Your Mouth Is
08/18/2022
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and...
08/18/2022
Journal of Clinical Pathways

Editor Insights

Quality Outlook
Every Second Counts: the Impact of FDA’s Accelerated Approval Program
03/05/2025
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research...
03/05/2025
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
Anne DiSalvo.
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination
10/03/2023
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part...
10/03/2023
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Jacqlyn Riposo
Quality Outlook
Focus on Outcomes: Quality Measurement Recommendations for CMS’ Medicaid Cell and Gene Therapy Access Model
06/08/2023
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers...
06/08/2023
Journal of Clinical Pathways
Sarena Ho, MSPH
Quality Outlook
Quality Measures for Medicare’s Enhancing Oncology Model (EOM): New and Improved or More of the Same?
01/26/2023
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center...
01/26/2023
Journal of Clinical Pathways
Nina Regenold, MSc
Quality Outlook
The Oncology-Oral Health Value Bridge: Put Your Money Where Your Mouth Is
08/18/2022
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and...
08/18/2022
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Performance-Based Risk Sharing Agreements for Devices and Diagnostics
03/04/2022
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a...
03/04/2022
Journal of Clinical Pathways
Quality Outlook
Every Second Counts: the Impact of FDA’s Accelerated Approval Program
03/05/2025
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research...
03/05/2025
Journal of Clinical Pathways
CPC + CBEx: Breaking down barriers and pushing boundaries of cancer care
Blog
CPC + CBEx: Breaking down barriers and pushing boundaries of cancer care
08/07/2024
At CPC+CBEx, we bring together stakeholders invested throughout the entire patient journey.
At CPC+CBEx, we bring together stakeholders invested throughout the entire patient journey.
At CPC+CBEx, we bring together...
08/07/2024
Journal of Clinical Pathways
Editor in chief Winston Wong, PharmD.
Editor Insights
Looking at 2023 Key Trends and Insights to Navigate the Future of Value-Based Care
02/13/2024
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature...
02/13/2024
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
Anne DiSalvo.
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination
10/03/2023
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part...
10/03/2023
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Jacqlyn Riposo
Quality Outlook
Focus on Outcomes: Quality Measurement Recommendations for CMS’ Medicaid Cell and Gene Therapy Access Model
06/08/2023
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers...
06/08/2023
Journal of Clinical Pathways
Winston Wong
Editor Insights
A Look Back at Clinical Pathways in 2022
02/21/2023
This blog summarizes the Journal of Clinical Pathway's top 5 articles of 2022.
This blog summarizes the Journal of Clinical Pathway's top 5 articles of 2022.
This blog summarizes the Journal...
02/21/2023
Journal of Clinical Pathways

Data Science for HCPs

The Guardrails of Data Science: Regulations and Certifications for Health Care
Data Science for HCPs
The Guardrails of Data Science: Regulations and Certifications for Health Care
01/20/2021
In this blog post, Michael Towbin and colleagues explore the guidelines intended to provide guardrails for data science efforts.
In this blog post, Michael Towbin and colleagues explore the guidelines intended to provide guardrails for data science efforts.
In this blog post, Michael...
01/20/2021
Journal of Clinical Pathways
Finding the Signal in the Noise During COVID-19: A Survey on Multiple Sclerosis
Data Science for HCPs
Finding the Signal in the Noise During COVID-19: A Survey on Multiple Sclerosis
06/25/2020
David Hughes, BSN, and colleagues break down the intersection between COVID-19 and multiple sclerosis, including how the virus has affected access to care and the wide adoption of telehealth care delivery.
David Hughes, BSN, and colleagues break down the intersection between COVID-19 and multiple sclerosis, including how the virus has affected access to care and the wide adoption of telehealth care delivery.
David Hughes, BSN, and...
06/25/2020
Journal of Clinical Pathways
Extraction, Transformation, and Loading: The ETL of Data Engineering
Data Science for HCPs
Extraction, Transformation, and Loading: The ETL of Data Engineering
05/18/2020
David Hughes, BSN, and colleagues explain data extraction in layman’s terms, including what it takes to wrangle data into a usable shape and the end result of data engineering.
David Hughes, BSN, and colleagues explain data extraction in layman’s terms, including what it takes to wrangle data into a usable shape and the end result of data engineering.
David Hughes, BSN, and...
05/18/2020
Journal of Clinical Pathways
Data Science for HCPs
Data Engineering: The Foundation of Data Science Efforts
04/09/2020
David Hughes, BSN, and colleagues detail the journey of data engineering from source to secure transport, storage, and versioning to its ultimate deployment.
David Hughes, BSN, and colleagues detail the journey of data engineering from source to secure transport, storage, and versioning to its ultimate deployment.
David Hughes, BSN, and...
04/09/2020
Journal of Clinical Pathways
Data Science for HCPs
What Is Data Science: Addressing the Uncertainty Behind Addressing Uncertainty
03/14/2020
David Hughes, BSN, and colleagues lay the foundation for understanding data science, drawing comparisons from chess and poker and the history of the scientific method.
David Hughes, BSN, and colleagues lay the foundation for understanding data science, drawing comparisons from chess and poker and the history of the scientific method.
David Hughes, BSN, and...
03/14/2020
Journal of Clinical Pathways
Data Science for HCPs
Introduction to Data Science for Health Care Professionals
02/11/2020
In the first installment of the new Data Science for Health Care Professionals blog series, David Hughes, BSN, Octave Bioscience, underscores the role of data in health care today and how this series will help make data science concepts more...
In the first installment of the new Data Science for Health Care Professionals blog series, David Hughes, BSN, Octave Bioscience, underscores the role of data in health care today and how this series will help make data science concepts more...
In the first installment of the...
02/11/2020
Journal of Clinical Pathways
The Guardrails of Data Science: Regulations and Certifications for Health Care
Data Science for HCPs
The Guardrails of Data Science: Regulations and Certifications for Health Care
01/20/2021
In this blog post, Michael Towbin and colleagues explore the guidelines intended to provide guardrails for data science efforts.
In this blog post, Michael Towbin and colleagues explore the guidelines intended to provide guardrails for data science efforts.
In this blog post, Michael...
01/20/2021
Journal of Clinical Pathways
Finding the Signal in the Noise During COVID-19: A Survey on Multiple Sclerosis
Data Science for HCPs
Finding the Signal in the Noise During COVID-19: A Survey on Multiple Sclerosis
06/25/2020
David Hughes, BSN, and colleagues break down the intersection between COVID-19 and multiple sclerosis, including how the virus has affected access to care and the wide adoption of telehealth care delivery.
David Hughes, BSN, and colleagues break down the intersection between COVID-19 and multiple sclerosis, including how the virus has affected access to care and the wide adoption of telehealth care delivery.
David Hughes, BSN, and...
06/25/2020
Journal of Clinical Pathways
Extraction, Transformation, and Loading: The ETL of Data Engineering
Data Science for HCPs
Extraction, Transformation, and Loading: The ETL of Data Engineering
05/18/2020
David Hughes, BSN, and colleagues explain data extraction in layman’s terms, including what it takes to wrangle data into a usable shape and the end result of data engineering.
David Hughes, BSN, and colleagues explain data extraction in layman’s terms, including what it takes to wrangle data into a usable shape and the end result of data engineering.
David Hughes, BSN, and...
05/18/2020
Journal of Clinical Pathways
Data Science for HCPs
Data Engineering: The Foundation of Data Science Efforts
04/09/2020
David Hughes, BSN, and colleagues detail the journey of data engineering from source to secure transport, storage, and versioning to its ultimate deployment.
David Hughes, BSN, and colleagues detail the journey of data engineering from source to secure transport, storage, and versioning to its ultimate deployment.
David Hughes, BSN, and...
04/09/2020
Journal of Clinical Pathways
Data Science for HCPs
What Is Data Science: Addressing the Uncertainty Behind Addressing Uncertainty
03/14/2020
David Hughes, BSN, and colleagues lay the foundation for understanding data science, drawing comparisons from chess and poker and the history of the scientific method.
David Hughes, BSN, and colleagues lay the foundation for understanding data science, drawing comparisons from chess and poker and the history of the scientific method.
David Hughes, BSN, and...
03/14/2020
Journal of Clinical Pathways
Data Science for HCPs
Introduction to Data Science for Health Care Professionals
02/11/2020
In the first installment of the new Data Science for Health Care Professionals blog series, David Hughes, BSN, Octave Bioscience, underscores the role of data in health care today and how this series will help make data science concepts more...
In the first installment of the new Data Science for Health Care Professionals blog series, David Hughes, BSN, Octave Bioscience, underscores the role of data in health care today and how this series will help make data science concepts more...
In the first installment of the...
02/11/2020
Journal of Clinical Pathways

Healthcare Economist

Jason Shafrin, PhD
Healthcare Economist
Performance-Based Risk Sharing Agreements for Devices and Diagnostics
03/04/2022
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a...
03/04/2022
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Distributional Cost-Effectiveness Analysis: A Simple Example
02/09/2022
Jason Shafrin, PhD, describes 6 key steps to implementing distributional cost-effectiveness analysis.
Jason Shafrin, PhD, describes 6 key steps to implementing distributional cost-effectiveness analysis.
Jason Shafrin, PhD, describes 6...
02/09/2022
Journal of Clinical Pathways
Shafrin
Healthcare Economist
Alternative Payment Models: Where Are We Now?
02/07/2022
Jason Shafrin, PhD, discusses a report from the Health Care Payment Learning and Action Network which assessed whether alternative payment models have gained market share from 2019 to 2020.
Jason Shafrin, PhD, discusses a report from the Health Care Payment Learning and Action Network which assessed whether alternative payment models have gained market share from 2019 to 2020.
Jason Shafrin, PhD, discusses a...
02/07/2022
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Impact of Biosimilar Entry on Drug Costs
12/20/2021
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a...
12/20/2021
Journal of Clinical Pathways
Shafrin
Healthcare Economist
Which Strategies Are Payers and Employers Using to Cover Ophan Drugs?
06/20/2021
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, discusses a...
06/20/2021
Journal of Clinical Pathways
Healthcare Economist
The Real Cost of Electronic Health Records
06/07/2021
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses...
06/07/2021
Journal of Clinical Pathways
Healthcare Economist
Impact of COVID-19 on CMS’ Value-Based Programs
06/01/2021
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses...
06/01/2021
Journal of Clinical Pathways
PCORI to Incorporate Cost But Not Cost-Effectiveness in its New Principles
Healthcare Economist
PCORI to Incorporate Cost But Not Cost-Effectiveness in its New Principles
10/09/2020
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles” for the Consideration of the Full Range of Outcomes Data.
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles” for the Consideration of the Full Range of Outcomes Data.
Jason Shafrin, PhD, highlights...
10/09/2020
Journal of Clinical Pathways
The Need for Continuous Cost-Effectiveness Analysis
Healthcare Economist
The Need for Continuous Cost-Effectiveness Analysis
07/06/2020
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a...
07/06/2020
Journal of Clinical Pathways
Are Value-Based Agreements the Solution to High Drug Prices?
Healthcare Economist
Are Value-Based Agreements the Solution to High Drug Prices?
05/26/2020
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides...
05/26/2020
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Performance-Based Risk Sharing Agreements for Devices and Diagnostics
03/04/2022
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a recent paper which reviewed publicly available data on performance-based risk sharing agreements for medical devices and diagnostics.
Jason Shafrin, PhD, discusses a...
03/04/2022
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Distributional Cost-Effectiveness Analysis: A Simple Example
02/09/2022
Jason Shafrin, PhD, describes 6 key steps to implementing distributional cost-effectiveness analysis.
Jason Shafrin, PhD, describes 6 key steps to implementing distributional cost-effectiveness analysis.
Jason Shafrin, PhD, describes 6...
02/09/2022
Journal of Clinical Pathways
Shafrin
Healthcare Economist
Alternative Payment Models: Where Are We Now?
02/07/2022
Jason Shafrin, PhD, discusses a report from the Health Care Payment Learning and Action Network which assessed whether alternative payment models have gained market share from 2019 to 2020.
Jason Shafrin, PhD, discusses a report from the Health Care Payment Learning and Action Network which assessed whether alternative payment models have gained market share from 2019 to 2020.
Jason Shafrin, PhD, discusses a...
02/07/2022
Journal of Clinical Pathways
Jason Shafrin, PhD
Healthcare Economist
Impact of Biosimilar Entry on Drug Costs
12/20/2021
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a paper examining how prices vary for branded, physician-administered drugs which had generic or biosimilar versions introduced before 2005.
Jason Shafrin, PhD, discusses a...
12/20/2021
Journal of Clinical Pathways
Shafrin
Healthcare Economist
Which Strategies Are Payers and Employers Using to Cover Ophan Drugs?
06/20/2021
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, discusses a survey which explored affordability challenges posed by orphan drugs from the payer, provider, and employer perspectives.
Jason Shafrin, PhD, discusses a...
06/20/2021
Journal of Clinical Pathways
Healthcare Economist
The Real Cost of Electronic Health Records
06/07/2021
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses the many cost aspects of successfully implementing electronic health records.
Jason Shafrin, PhD, discusses...
06/07/2021
Journal of Clinical Pathways
Healthcare Economist
Impact of COVID-19 on CMS’ Value-Based Programs
06/01/2021
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses the effect quality impacts during COVID-19 will have on Medicare reimbursement to providers through 2024.
Jason Shafrin, PhD, discusses...
06/01/2021
Journal of Clinical Pathways
PCORI to Incorporate Cost But Not Cost-Effectiveness in its New Principles
Healthcare Economist
PCORI to Incorporate Cost But Not Cost-Effectiveness in its New Principles
10/09/2020
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles” for the Consideration of the Full Range of Outcomes Data.
Jason Shafrin, PhD, highlights the Patient-Centered Outcomes Research Institute's (PCORI) Proposed “Principles” for the Consideration of the Full Range of Outcomes Data.
Jason Shafrin, PhD, highlights...
10/09/2020
Journal of Clinical Pathways
The Need for Continuous Cost-Effectiveness Analysis
Healthcare Economist
The Need for Continuous Cost-Effectiveness Analysis
07/06/2020
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a study noting that value assessment is not a one-time endeavor but needs to be revisited as a treatment landscape evolves.
Jason Shafrin, PhD, highlights a...
07/06/2020
Journal of Clinical Pathways
Are Value-Based Agreements the Solution to High Drug Prices?
Healthcare Economist
Are Value-Based Agreements the Solution to High Drug Prices?
05/26/2020
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides commentary on why value-based agreements will likely never make up the majority of drug reimbursement.
Jason Shafrin, PhD, provides...
05/26/2020
Journal of Clinical Pathways

Quality Outlook

David Blaisdell
Quality Outlook
Measuring Adherence to Oral Anticancer Medications: A Persistent Problem
06/06/2024
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the...
06/06/2024
Journal of Clinical Pathways
Veronica Ellis
Quality Outlook
Transform HIV Prevention in Your Practice With a New Quality Initiative
05/01/2024
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an...
05/01/2024
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
Anne DiSalvo.
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination
10/03/2023
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part...
10/03/2023
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Jacqlyn Riposo
Quality Outlook
Focus on Outcomes: Quality Measurement Recommendations for CMS’ Medicaid Cell and Gene Therapy Access Model
06/08/2023
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers...
06/08/2023
Journal of Clinical Pathways
Sarena Ho, MSPH
Quality Outlook
Quality Measures for Medicare’s Enhancing Oncology Model (EOM): New and Improved or More of the Same?
01/26/2023
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center...
01/26/2023
Journal of Clinical Pathways
Nina Regenold, MSc
Quality Outlook
The Oncology-Oral Health Value Bridge: Put Your Money Where Your Mouth Is
08/18/2022
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and...
08/18/2022
Journal of Clinical Pathways
David Blaisdell
Quality Outlook
Measuring Adherence to Oral Anticancer Medications: A Persistent Problem
06/06/2024
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the...
06/06/2024
Journal of Clinical Pathways
Veronica Ellis
Quality Outlook
Transform HIV Prevention in Your Practice With a New Quality Initiative
05/01/2024
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an...
05/01/2024
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
Anne DiSalvo.
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination
10/03/2023
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part...
10/03/2023
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Jacqlyn Riposo
Quality Outlook
Focus on Outcomes: Quality Measurement Recommendations for CMS’ Medicaid Cell and Gene Therapy Access Model
06/08/2023
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers...
06/08/2023
Journal of Clinical Pathways
Sarena Ho, MSPH
Quality Outlook
Quality Measures for Medicare’s Enhancing Oncology Model (EOM): New and Improved or More of the Same?
01/26/2023
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center...
01/26/2023
Journal of Clinical Pathways
Nina Regenold, MSc
Quality Outlook
The Oncology-Oral Health Value Bridge: Put Your Money Where Your Mouth Is
08/18/2022
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and...
08/18/2022
Journal of Clinical Pathways

Guest Blogs

Jason Shafrin, PhD, FTI Consulting
Guest Blog
Has Medicine Reached the Digital Age? Five Key Obstacles Digital Technologies Still Need to Overcome
08/26/2021
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David...
08/26/2021
Journal of Clinical Pathways
How Cloud Computing Can Be the Key to Ameliorating Outcomes While Mitigating Health Care Costs
Guest Blog
How Cloud Computing Can Be the Key to Ameliorating Outcomes While Mitigating Health Care Costs
04/16/2021
Rahul Varshneya discusses a few ways cloud computing can support the health care industry’s efforts to improve patient outcomes while mitigating costs.
Rahul Varshneya discusses a few ways cloud computing can support the health care industry’s efforts to improve patient outcomes while mitigating costs.
Rahul Varshneya discusses a few...
04/16/2021
Journal of Clinical Pathways
How Digital Solutions Help Drive Patient-Focused Health Care
Guest Blog
How Digital Solutions Help Drive Patient-Focused Health Care
02/18/2021
In this blog post, Leo P Langlois, MD, PT, explores how digital technological solutions can help drive patient-focused care and improve outcomes.
In this blog post, Leo P Langlois, MD, PT, explores how digital technological solutions can help drive patient-focused care and improve outcomes.
In this blog post, Leo P...
02/18/2021
Journal of Clinical Pathways
Guest Blog
Adapting Pathways in a Pandemic
05/08/2020
Gordon Kuntz, Partner, Kuntz Consulting, lists ways that oncology pathways should change in the wake of COVID-19, including guidelines for treating patients with COVID-19 and strategies for minimizing contact time.
Gordon Kuntz, Partner, Kuntz Consulting, lists ways that oncology pathways should change in the wake of COVID-19, including guidelines for treating patients with COVID-19 and strategies for minimizing contact time.
Gordon Kuntz, Partner, Kuntz...
05/08/2020
Journal of Clinical Pathways
Guest Blog
Deprescribing: A Tool for Cost Reduction and Improved Outcomes?
07/11/2019
Marsha K Millonig, MBA, BPharm, explains how deprescribing may be a tool to address lowering health care and prescription drug costs if used widely.
Marsha K Millonig, MBA, BPharm, explains how deprescribing may be a tool to address lowering health care and prescription drug costs if used widely.
Marsha K Millonig, MBA, BPharm,...
07/11/2019
Journal of Clinical Pathways
Guest Blog
Achieving “Victory” Through Holistic Palliative Care
07/03/2019
Adil Akhtar, MD, offers the perspective that, if patients can learn to see their bodies as more important than their cancer, they will be more likely to agree to and continue palliative care.
Adil Akhtar, MD, offers the perspective that, if patients can learn to see their bodies as more important than their cancer, they will be more likely to agree to and continue palliative care.
Adil Akhtar, MD, offers the...
07/03/2019
Journal of Clinical Pathways
Guest Blog
Pharmacogenomics: Preemptive Testing Decisions Reach Across the Care Team
01/07/2019
Kandace Schuft, PharmD, discusses the challenges of implementing pharmacogenomics testing in actual practice and determining its place in the workflow of multiple care teams.
Kandace Schuft, PharmD, discusses the challenges of implementing pharmacogenomics testing in actual practice and determining its place in the workflow of multiple care teams.
Kandace Schuft, PharmD,...
01/07/2019
Journal of Clinical Pathways
Guest Blog
Health Insurance Aside, Americans Still Struggle to Pay for Their Medications
12/14/2018
More than 40% of Americans are struggling to pay for the cost of their medications, even though nearly all of them have some kind of health insurance coverage, a recent survey found.
More than 40% of Americans are struggling to pay for the cost of their medications, even though nearly all of them have some kind of health insurance coverage, a recent survey found.
More than 40% of Americans are...
12/14/2018
Journal of Clinical Pathways
Guest Blog
Potential Administrative Burdens in Oncology Clinical Pathways
05/07/2018
Sowmya Josyula, MD, MPH, and Bobby Daly, MD, MBA, discuss the most commonly recognized administrative barriers faced by physicians using oncology clinical pathways and argue that addressing these burdens is crucial in ensuring provider...
Sowmya Josyula, MD, MPH, and Bobby Daly, MD, MBA, discuss the most commonly recognized administrative barriers faced by physicians using oncology clinical pathways and argue that addressing these burdens is crucial in ensuring provider...
Sowmya Josyula, MD, MPH, and...
05/07/2018
Journal of Clinical Pathways
Guest Blog
Why Palliative Care is More Than Just Care for the Dying
04/28/2018
Many physicians still mistakenly believe that hospice and palliative medicine are one and the same, according to Timothy W Holder, MD, medical director, supportive care and survivorship, Cancer Treatment Centers of America.
Many physicians still mistakenly believe that hospice and palliative medicine are one and the same, according to Timothy W Holder, MD, medical director, supportive care and survivorship, Cancer Treatment Centers of America.
Many physicians still mistakenly...
04/28/2018
Journal of Clinical Pathways
Jason Shafrin, PhD, FTI Consulting
Guest Blog
Has Medicine Reached the Digital Age? Five Key Obstacles Digital Technologies Still Need to Overcome
08/26/2021
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David Gruber, MD, MBA, discuss challenges digital health innovators face and what digital health technologies must provide to be successful.
Jason Shafrin, PhD, and David...
08/26/2021
Journal of Clinical Pathways
How Cloud Computing Can Be the Key to Ameliorating Outcomes While Mitigating Health Care Costs
Guest Blog
How Cloud Computing Can Be the Key to Ameliorating Outcomes While Mitigating Health Care Costs
04/16/2021
Rahul Varshneya discusses a few ways cloud computing can support the health care industry’s efforts to improve patient outcomes while mitigating costs.
Rahul Varshneya discusses a few ways cloud computing can support the health care industry’s efforts to improve patient outcomes while mitigating costs.
Rahul Varshneya discusses a few...
04/16/2021
Journal of Clinical Pathways
How Digital Solutions Help Drive Patient-Focused Health Care
Guest Blog
How Digital Solutions Help Drive Patient-Focused Health Care
02/18/2021
In this blog post, Leo P Langlois, MD, PT, explores how digital technological solutions can help drive patient-focused care and improve outcomes.
In this blog post, Leo P Langlois, MD, PT, explores how digital technological solutions can help drive patient-focused care and improve outcomes.
In this blog post, Leo P...
02/18/2021
Journal of Clinical Pathways
Guest Blog
Adapting Pathways in a Pandemic
05/08/2020
Gordon Kuntz, Partner, Kuntz Consulting, lists ways that oncology pathways should change in the wake of COVID-19, including guidelines for treating patients with COVID-19 and strategies for minimizing contact time.
Gordon Kuntz, Partner, Kuntz Consulting, lists ways that oncology pathways should change in the wake of COVID-19, including guidelines for treating patients with COVID-19 and strategies for minimizing contact time.
Gordon Kuntz, Partner, Kuntz...
05/08/2020
Journal of Clinical Pathways
Guest Blog
Deprescribing: A Tool for Cost Reduction and Improved Outcomes?
07/11/2019
Marsha K Millonig, MBA, BPharm, explains how deprescribing may be a tool to address lowering health care and prescription drug costs if used widely.
Marsha K Millonig, MBA, BPharm, explains how deprescribing may be a tool to address lowering health care and prescription drug costs if used widely.
Marsha K Millonig, MBA, BPharm,...
07/11/2019
Journal of Clinical Pathways
Guest Blog
Achieving “Victory” Through Holistic Palliative Care
07/03/2019
Adil Akhtar, MD, offers the perspective that, if patients can learn to see their bodies as more important than their cancer, they will be more likely to agree to and continue palliative care.
Adil Akhtar, MD, offers the perspective that, if patients can learn to see their bodies as more important than their cancer, they will be more likely to agree to and continue palliative care.
Adil Akhtar, MD, offers the...
07/03/2019
Journal of Clinical Pathways
Guest Blog
Pharmacogenomics: Preemptive Testing Decisions Reach Across the Care Team
01/07/2019
Kandace Schuft, PharmD, discusses the challenges of implementing pharmacogenomics testing in actual practice and determining its place in the workflow of multiple care teams.
Kandace Schuft, PharmD, discusses the challenges of implementing pharmacogenomics testing in actual practice and determining its place in the workflow of multiple care teams.
Kandace Schuft, PharmD,...
01/07/2019
Journal of Clinical Pathways
Guest Blog
Health Insurance Aside, Americans Still Struggle to Pay for Their Medications
12/14/2018
More than 40% of Americans are struggling to pay for the cost of their medications, even though nearly all of them have some kind of health insurance coverage, a recent survey found.
More than 40% of Americans are struggling to pay for the cost of their medications, even though nearly all of them have some kind of health insurance coverage, a recent survey found.
More than 40% of Americans are...
12/14/2018
Journal of Clinical Pathways
Guest Blog
Potential Administrative Burdens in Oncology Clinical Pathways
05/07/2018
Sowmya Josyula, MD, MPH, and Bobby Daly, MD, MBA, discuss the most commonly recognized administrative barriers faced by physicians using oncology clinical pathways and argue that addressing these burdens is crucial in ensuring provider...
Sowmya Josyula, MD, MPH, and Bobby Daly, MD, MBA, discuss the most commonly recognized administrative barriers faced by physicians using oncology clinical pathways and argue that addressing these burdens is crucial in ensuring provider...
Sowmya Josyula, MD, MPH, and...
05/07/2018
Journal of Clinical Pathways
Guest Blog
Why Palliative Care is More Than Just Care for the Dying
04/28/2018
Many physicians still mistakenly believe that hospice and palliative medicine are one and the same, according to Timothy W Holder, MD, medical director, supportive care and survivorship, Cancer Treatment Centers of America.
Many physicians still mistakenly believe that hospice and palliative medicine are one and the same, according to Timothy W Holder, MD, medical director, supportive care and survivorship, Cancer Treatment Centers of America.
Many physicians still mistakenly...
04/28/2018
Journal of Clinical Pathways

Payer Voice

Quality Outlook
Every Second Counts: the Impact of FDA’s Accelerated Approval Program
03/05/2025
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research...
03/05/2025
Journal of Clinical Pathways
David Blaisdell
Quality Outlook
Measuring Adherence to Oral Anticancer Medications: A Persistent Problem
06/06/2024
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the...
06/06/2024
Journal of Clinical Pathways
Veronica Ellis
Quality Outlook
Transform HIV Prevention in Your Practice With a New Quality Initiative
05/01/2024
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an...
05/01/2024
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
Anne DiSalvo.
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination
10/03/2023
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part...
10/03/2023
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Jacqlyn Riposo
Quality Outlook
Focus on Outcomes: Quality Measurement Recommendations for CMS’ Medicaid Cell and Gene Therapy Access Model
06/08/2023
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers...
06/08/2023
Journal of Clinical Pathways
Sarena Ho, MSPH
Quality Outlook
Quality Measures for Medicare’s Enhancing Oncology Model (EOM): New and Improved or More of the Same?
01/26/2023
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center...
01/26/2023
Journal of Clinical Pathways
Videos
Progress and Unmet Needs in Post-IO Treatment for Metastatic RCC
03/19/2025
In this interview, Dr Neil Shah discusses the challenges of treatment sequencing for metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitor therapy, highlighting findings from his study on post-IO treatment efficacy and the...
In this interview, Dr Neil Shah discusses the challenges of treatment sequencing for metastatic renal cell carcinoma (mRCC) after immune checkpoint inhibitor therapy, highlighting findings from his study on post-IO treatment efficacy and the...
In this interview, Dr Neil Shah...
03/19/2025
Journal of Clinical Pathways
News
Academic Cancer Centers Improve Outcomes for Patients With Mantle Cell Lymphoma
03/18/2025
Patients with mantle cell lymphoma (MCL) who receive treatment at academic cancer centers experience longer overall survival and higher participation in clinical trials compared to those treated in community-based practices, according to a...
Patients with mantle cell lymphoma (MCL) who receive treatment at academic cancer centers experience longer overall survival and higher participation in clinical trials compared to those treated in community-based practices, according to a...
Patients with mantle cell...
03/18/2025
Journal of Clinical Pathways
Graf Headshot
Interview
The Future of Chronic Lymphocytic Leukemia Management with Targeted Therapies
03/17/2025
In this interview, an expert discusses the preclinical development and clinical impact of zanubrutinib in chronic lymphocytic leukemia, highlighting key findings from pivotal trials, comparisons with other therapies, and future research...
In this interview, an expert discusses the preclinical development and clinical impact of zanubrutinib in chronic lymphocytic leukemia, highlighting key findings from pivotal trials, comparisons with other therapies, and future research...
In this interview, an expert...
03/17/2025
Journal of Clinical Pathways
Oncology Innovations
Videos
Advancing Value-Based Oncology With the Predictable Cost of Care Working Group: Part 2
03/17/2025
In this episode of Oncology Innovations, experts discuss the Predictable Cost of Care Working Group’s efforts to develop a standardized model for assessing oncology treatment costs, highlighting insights from phase I, the goals of phase II,...
In this episode of Oncology Innovations, experts discuss the Predictable Cost of Care Working Group’s efforts to develop a standardized model for assessing oncology treatment costs, highlighting insights from phase I, the goals of phase II,...
In this episode of Oncology...
03/17/2025
Journal of Clinical Pathways
News
Improving Health Care Access for Immigrants With Disabilities in North America
03/14/2025
Exploring the barriers and facilitators of immigrants with disabilities accessing health care in the US and Canada, this qualitative meta-synthesis reveals the structural and cultural obstacles faced by this marginalized population and calls...
Exploring the barriers and facilitators of immigrants with disabilities accessing health care in the US and Canada, this qualitative meta-synthesis reveals the structural and cultural obstacles faced by this marginalized population and calls...
Exploring the barriers and...
03/14/2025
Journal of Clinical Pathways
News
AI Revolutionizes Early Detection and Diagnosis of Gastric Cancer
03/14/2025
Artificial intelligence (AI) is rapidly transforming the landscape of early gastric cancer (EGC) detection and treatment, offering promising solutions to improve diagnostic accuracy, treatment planning, and patient outcomes, according to an...
Artificial intelligence (AI) is rapidly transforming the landscape of early gastric cancer (EGC) detection and treatment, offering promising solutions to improve diagnostic accuracy, treatment planning, and patient outcomes, according to an...
Artificial intelligence (AI) is...
03/14/2025
Journal of Clinical Pathways
Brian S.
Interview
Key Advancements in Immunotherapy for Endometrial Cancer
03/13/2025
A guest expert discusses groundbreaking research on pembrolizumab in adjuvant treatment for endometrial cancer, highlighting the significant impact on reducing recurrence risk in patients with deficient mismatch repair and the need for...
A guest expert discusses groundbreaking research on pembrolizumab in adjuvant treatment for endometrial cancer, highlighting the significant impact on reducing recurrence risk in patients with deficient mismatch repair and the need for...
A guest expert discusses...
03/13/2025
Journal of Clinical Pathways
News
Oral JAK2 Inhibitor Offers a Viable Second-Line Treatment for Myelofibrosis, But Challenges Remain
03/13/2025
Fedratinib, an oral JAK2 inhibitor, has demonstrated efficacy in treating myelofibrosis (MF), particularly in patients who have failed ruxolitinib therapy, according to a study published in the Blood Cancer Journal.
Fedratinib, an oral JAK2 inhibitor, has demonstrated efficacy in treating myelofibrosis (MF), particularly in patients who have failed ruxolitinib therapy, according to a study published in the Blood Cancer Journal.
Fedratinib, an oral JAK2...
03/13/2025
Journal of Clinical Pathways
News
Early Measurable Residual Disease Assessment Predicts Survival in Patients With Mantle Cell Lymphoma
03/12/2025
Patients with mantle cell lymphoma (MCL) can benefit from measurable residual disease (MRD) assessment during induction therapy, with the timing and kinetics of MRD negativity significantly impacting prognosis and treatment strategies,...
Patients with mantle cell lymphoma (MCL) can benefit from measurable residual disease (MRD) assessment during induction therapy, with the timing and kinetics of MRD negativity significantly impacting prognosis and treatment strategies,...
Patients with mantle cell...
03/12/2025
Journal of Clinical Pathways
Brufsky Headshot
Interview
Transforming Metastatic Breast Cancer Care With AI and Real-World Evidence
03/11/2025
In this interview, Adam Brufsky, MD, PhD, discusses the evolving treatment landscape for hormone receptor-positive/HER2-negative metastatic breast cancer, the impact of CDK4/6 inhibitors, the role of genomic assays and artificial intelligence...
In this interview, Adam Brufsky, MD, PhD, discusses the evolving treatment landscape for hormone receptor-positive/HER2-negative metastatic breast cancer, the impact of CDK4/6 inhibitors, the role of genomic assays and artificial intelligence...
In this interview, Adam Brufsky,...
03/11/2025
Journal of Clinical Pathways
JCP January/February 2025

Current Issue

February 2025
Volume 11
Issue 1
Current Issue
Issue Archive

Special Reports

Page 1
Special Report
Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer
02/19/2025
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care Working Group developed a model that can be used by various entities evaluating the impact of treatment on the total cost of care.
The Predictable Cost of Care...
02/19/2025
Journal of Clinical Pathways
JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Subscribe

Journal of Clinical Pathways Newsletter

Recent Stories

Quality Outlook
Every Second Counts: the Impact of FDA’s Accelerated Approval Program
03/05/2025
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research highlights the significant impact of the FDA’s Accelerated Approval Program, estimating that earlier access to cancer therapies has provided approximately 263 000 additional life years to patients, reinforcing the...
Johnson & Johnson’s research...
03/05/2025
Journal of Clinical Pathways
David Blaisdell
Quality Outlook
Measuring Adherence to Oral Anticancer Medications: A Persistent Problem
06/06/2024
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the importance of medication adherence and persistence in oncology, and how the Pharmacy Quality Alliance (PQA) is tackling the problem by exploring the construction of oral anticancer medication measures.
This blog post discusses the...
06/06/2024
Journal of Clinical Pathways
Veronica Ellis
Quality Outlook
Transform HIV Prevention in Your Practice With a New Quality Initiative
05/01/2024
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an overview of the the Centers for Medicare & Medicaid Services' Merit-based Incentive Payment System HIV Prevention Improvement Activity and how it can enhance quality of care while advancing HIV prevention.
This blog post provides an...
05/01/2024
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use